Trial · NCT02844998
The Impact and Benefit of Physical Activity on Premature Ejaculation
NCT02844998, Not applicable, Completed, Ankara Training and Research Hospital; results first posted 2017-09-29
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Impact and Benefit of Physical Activity on Premature Ejaculation. Trials, record NCT02844998. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02844998
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Impact and Benefit of Physical Activity on Premature Ejaculation
- NCT number
- NCT02844998
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 120 participants, actual
- Lead sponsor
- Ankara Training and Research Hospital
- Conditions
- Premature Ejaculation
- Interventions
- physical activity, dapoxetine 30 mg on demand
- First posted
- 2016-07-26
- Last updated
- 2017-09-29
- Results first posted
- 2017-09-29
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Premature Ejaculation Diagnostic Tool (Total Score) | Baseline and 30 Days | Premature Ejaculation Diagnostic Tool (PEDT) includes five items; control, frequency, minimal stimulation, distress, and interpersonal difficulty. In this classification tool, equal to or less than scores 8 indicates no PE, scores 9 and 10 indicate possible PE, and scores equal or higher than 11 indicates PE. Total score is between 2 and 22. |
| Primary | Intravaginal Ejaculatory Latency Time | Baseline and 30 Days | Duration determined by the sexual partner with stopwatch method, and \<1 minute was considered as PE. (minimum/maximum scores were not possible) |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Premature Ejaculation Diagnostic Tool (Total Score) | Baseline and 30 Days | scores on a scale | MEAN | |
| PRIMARY | Intravaginal Ejaculatory Latency Time | Baseline and 30 Days | seconds | MEAN |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Premature Ejaculation Diagnostic Tool (Total Score) | Group 1 | baseline data | 14.5 | Standard Deviation 1.9 | scores on a scale |
| Premature Ejaculation Diagnostic Tool (Total Score) | Group 2 | baseline data | 13.7 | Standard Deviation 1.8 | scores on a scale |
| Premature Ejaculation Diagnostic Tool (Total Score) | Sham-controlled | baseline data | 13.7 | Standard Deviation 2.2 | scores on a scale |
| Premature Ejaculation Diagnostic Tool (Total Score) | Group 1 | end of study data | 8.9 | Standard Deviation 2.5 | scores on a scale |
| Premature Ejaculation Diagnostic Tool (Total Score) | Group 2 | end of study data | 7.8 | Standard Deviation 2.9 | scores on a scale |
| Premature Ejaculation Diagnostic Tool (Total Score) | Sham-controlled | end of study data | 12.8 | Standard Deviation 1.7 | scores on a scale |
| Intravaginal Ejaculatory Latency Time | Group 1 | baseline data | 36.8 | Standard Deviation 13.1 | seconds |
| Intravaginal Ejaculatory Latency Time | Group 2 | baseline data | 39.3 | Standard Deviation 8.8 | seconds |
| Intravaginal Ejaculatory Latency Time | Sham-controlled | baseline data | 33.8 | Standard Deviation 14.7 | seconds |
| Intravaginal Ejaculatory Latency Time | Group 1 | end of study data | 181.7 | Standard Deviation 88.8 | seconds |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Group 1 | 42 | |
| Overall Study | STARTED | Group 2 | 39 | |
| Overall Study | STARTED | Sham-controlled | 39 | |
| Overall Study | COMPLETED | Group 1 | 35 | |
| Overall Study | COMPLETED | Group 2 | 35 | |
| Overall Study | COMPLETED | Sham-controlled | 35 | |
| Overall Study | NOT COMPLETED | Group 1 | 7 | |
| Overall Study | NOT COMPLETED | Group 2 | 4 | |
| Overall Study | NOT COMPLETED | Sham-controlled | 4 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Group 1 | 0 | 35 |
| Total, all-cause mortality | Group 2 | 0 | 35 |
| Total, all-cause mortality | Sham-controlled | 0 | 35 |
| Total, other adverse events | Group 1 | 0 | 35 |
| Total, other adverse events | Group 2 | 0 | 35 |
| Total, other adverse events | Sham-controlled | 0 | 35 |
| Total, serious adverse events | Group 1 | 0 | 35 |
| Total, serious adverse events | Group 2 | 0 | 35 |
| Total, serious adverse events | Sham-controlled | 0 | 35 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02844998
GET https://conductscience.org/api/trials/v1/NCT02844998/registered